Matrixx Initiatives (MTXX): FQ1 EPS of -$2.49 vs. -$0.19 (one estimate). Revenue of $6.9M (-19%)...

Matrixx Initiatives (MTXX): FQ1 EPS of -$2.49 vs. -$0.19 (one estimate). Revenue of $6.9M (-19%) vs. $9M. EPS includes $9M charge for recall of Cold Remedy products and $24M charge for impairment. Shares -10.3% AH. (PR)